News
HOTH
0.6659
+1.46%
0.0096
Weekly Report: what happened at HOTH last week (0504-0508)?
Weekly Report · 4d ago
Hoth Therapeutics Launches Rocket One Space Subsidiary Initiative
TipRanks · 05/06 20:59
Hoth Therapeutics forms space-industry subsidiary Rocket One
PUBT · 05/06 20:31
Hoth Therapeutics wins Spain authorization for HT-001 Phase 2a trial
PUBT · 05/05 20:47
Hoth Therapeutics Secures Regulatory Authorization In Spain For Phase 2a CLEER Trial Of HT-001
Benzinga · 05/05 20:29
HOTH THERAPEUTICS INC - NO TREATMENT-LIMITING ADVERSE EVENTS OBSERVED IN HT-001 PHASE 2A TRIAL
Reuters · 05/05 20:17
Hoth Therapeutics Secures European Authorization in Spain for HT-001 Phase 2a Trial as Interim Data Show Strong Efficacy in Cancer Patients
PR Newswire · 05/05 20:17
Hoth Therapeutics Receives Nasdaq Minimum Bid Price Deficiency Notice
TipRanks · 05/04 23:15
Hoth Therapeutics risks Nasdaq delisting after shares fall below $1 bid requirement
PUBT · 05/04 21:26
Weekly Report: what happened at HOTH last week (0427-0501)?
Weekly Report · 05/04 09:25
Weekly Report: what happened at HOTH last week (0420-0424)?
Weekly Report · 04/27 09:26
Weekly Report: what happened at HOTH last week (0413-0417)?
Weekly Report · 04/20 09:25
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 04/17 12:05
Hoth Therapeutics Resumes At-the-Market Equity Offering Program
TipRanks · 04/16 22:01
Hoth Therapeutics to resume at-the-market stock sales under H.C. Wainwright agreement
PUBT · 04/16 21:20
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga · 04/14 21:05
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 04/14 17:05
Move Over Novo Nordisk - This Small Company Study Flags Edge In Fatty Liver Drug
Benzinga · 04/14 16:30
BUZZ-U.S. STOCKS ON THE MOVE-Bloom, J&J, CarMax
Reuters · 04/14 15:40
BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Nano-X, Travere
Reuters · 04/14 13:15
More
Webull provides a variety of real-time HOTH stock news. You can receive the latest news about Hoth Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.
About HOTH
Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical needs. The Company is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT), and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The Company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004), and a treatment for obesity, and obesity-related diseases and conditions (HT-VA).